| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Cavia porcellus |
ED50 |
16.0 |
mg.kg-1 |
10.1021/jm00003a014 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
48.0 |
mg.kg-1 |
10.1021/jm00003a014 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Sigma-1 receptor |
IC50 |
15.2 |
nM |
10.1016/j.bmc.2007.10.037 |
| Cavia porcellus |
Sigma-1 receptor |
IC50 |
232.0 |
nM |
10.1016/j.bmc.2007.10.037 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
10.0 |
nM |
10.1021/acs.jmedchem.0c01964 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
63.0 |
nM |
10.1021/acs.jmedchem.0c01964 |
| Cavia porcellus |
Sigma-1 receptor |
Ratio Ki |
6.3 |
None |
10.1021/acs.jmedchem.0c01964 |
| Chlorocebus sabaeus |
Vero C1008 |
AUC cytotoxicity |
296.5 |
None |
10.1038/s41586-020-2286-9 |
| Chlorocebus sabaeus |
Vero C1008 |
pCC50 |
6.06 |
None |
10.1038/s41586-020-2286-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde oxidase |
Fm |
0.39 |
None |
10.1124/dmd.112.045195 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
3578.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
5221.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
11171.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
57.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
2511.89 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
CL |
0.034 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
40.8 |
nM |
10.1016/j.ejmech.2022.114512 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
43.0 |
nM |
10.1016/j.ejmech.2022.114581 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
1800.0 |
nM |
10.1021/jm0209578 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
3400.0 |
nM |
10.1021/jm0508538 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
94.37 |
% |
10.1021/acs.jmedchem.0c00456 |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1124/dmd.110.037630 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Km |
1400.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Vmax |
140.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
CL |
nan |
None |
10.1021/acs.jmedchem.7b01465 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutamate [NMDA] receptor |
Ki |
1680.0 |
nM |
10.1021/jm9704412 |
| Homo sapiens |
HERG |
AC50 |
21139.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
10.1021/acs.jmedchem.7b01465 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-23.12 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-1.57 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
Activity |
24.0 |
% |
10.1021/jm060728b |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
2967.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver |
CL |
123.33 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.7b00746 |
| Homo sapiens |
Liver |
T1/2 |
0.6525 |
hr |
10.1021/acs.jmedchem.6b01163 |
| Homo sapiens |
Liver microsome |
CL |
0.0542 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
CL |
0.0841 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
CL |
13.0 |
mL.min-1.g-1 |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
CL |
14.0 |
mL.min-1.g-1 |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
CLH |
21.9 |
uL/min |
10.1016/j.bmcl.2016.06.001 |
| Homo sapiens |
Liver microsome |
Fu |
0.72 |
None |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
Fu |
0.93 |
None |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
Km |
5000.0 |
nM |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
Km |
6320.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
Km |
7160.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
T1/2 |
1.053 |
hr |
10.1016/j.bmcl.2016.06.001 |
| Homo sapiens |
Liver microsome |
T1/2 |
1.542 |
hr |
10.1016/j.ejmech.2015.08.042 |
| Homo sapiens |
Liver microsome |
T1/2 |
2.567 |
hr |
10.1016/j.ejmech.2015.08.042 |
| Homo sapiens |
Liver microsome |
Vmax |
0.066 |
nmol/min |
10.1124/dmd.111.042200 |
| Homo sapiens |
Liver microsome |
Vmax |
309.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
Vmax |
590.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsomes |
CL |
10.7 |
mL.min-1.g-1 |
10.1021/jm101073q |
| Homo sapiens |
Liver microsomes |
T1/2 |
2.15 |
hr |
10.1021/jm101073q |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
2700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
6939.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1021/tx010125x |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
5700.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
5795.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
130.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
2.71 |
nM |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
1.44 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
348.0 |
nM |
10.1016/j.bmcl.2003.12.105 |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Skin |
log Kp |
-4.55 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
0.8 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
1.1 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
1.3 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
10450.0 |
nM |
10.1021/acs.jmedchem.6b01317 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
15000.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Ratio |
1.26 |
None |
10.1021/acs.jmedchem.6b01317 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
36.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
-21.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
15.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Taste receptor type 2 member 46 |
Activity |
nan |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
EC50 |
31000.0 |
nM |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.051 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.056 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.071 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.112 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.12 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.124 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.129 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.143 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.164 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.192 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.249 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.316 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.417 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.443 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.539 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
0.624 |
None |
None |
| Homo sapiens |
Taste receptor type 2 member 46 |
Ratio |
1.106 |
None |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
6.3 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
5.38 |
min |
10.1007/s00044-012-9977-1 |
| Mus musculus |
Liver |
T1/2 |
0.0185 |
hr |
10.1021/acsmedchemlett.7b00202 |
| Mus musculus |
Liver |
T1/2 |
0.1298 |
hr |
10.1021/acs.jmedchem.6b01163 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cytochrome P450 2D1 |
IC50 |
264000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D18 |
IC50 |
136000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D2 |
IC50 |
5600.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D3 |
IC50 |
18600.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate NMDA receptor |
IC50 |
1320.0 |
nM |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Inhibition |
2.0 |
% |
10.1021/jm00039a008 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ki |
2246.0 |
nM |
10.1021/jm00039a008 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ki |
4540.0 |
nM |
10.1016/j.bmc.2009.03.025 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.2 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.37 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.43 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.45 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.64 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.7 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
log(RatioIC50) |
0.93 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
1.6 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
2.34 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
2.7 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
3.01 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
4.41 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
5.06 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio IC50 |
8.49 |
None |
10.1016/j.bmcl.2015.08.017 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ratio Ki |
0.7 |
None |
10.1016/j.bmc.2009.03.025 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
2943.7 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
3981.1 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
17782.8 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
Ki |
10000.0 |
nM |
10.1021/jm00039a008 |
| Rattus norvegicus |
Neuronal acetylcholine receptor; alpha3/beta4 |
IC50 |
11050.0 |
nM |
10.1016/j.bmc.2014.10.036 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmc.2014.10.036 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
12.9 |
mg.kg-1 |
10.1016/s0960-894x(99)00415-1 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
nan |
% |
10.1016/j.bmc.2014.10.036 |
| Rattus norvegicus |
Rattus norvegicus |
TD50 |
nan |
None |
10.1016/s0960-894x(99)00415-1 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Sigma opioid receptor |
Ki |
5070.0 |
nM |
10.1021/jm00039a008 |
| Rattus norvegicus |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
1300.0 |
nM |
10.1016/s0960-894x(99)00415-1 |
| Rattus norvegicus |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
10000.0 |
nM |
10.1021/jm020875j |
| Rattus norvegicus |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
100000.0 |
nM |
10.1016/s0960-894x(99)00415-1 |
| Rattus norvegicus |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
5.0 |
% |
10.1021/jm020875j |
| Rattus norvegicus |
Sodium channel alpha subunits; brain (Types I, II, III) |
Ki |
4800.0 |
nM l-1 hr-1 |
10.1021/jm020875j |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Activity |
nan |
None |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
AUC |
271.2 |
None |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.09056 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
7762.47 |
nM |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
Activity |
nan |
None |
10.1124/dmd.112.050054 |
| None |
ADMET |
AUC Ratio |
1.093 |
None |
10.1038/s41586-020-2286-9 |
| None |
ADMET |
CL |
12.8 |
mL.min-1.g-1 |
10.1016/j.bmc.2017.09.037 |
| None |
ADMET |
CL |
14.8 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
CL |
24.2 |
mL.min-1.g-1 |
10.1016/j.bmc.2017.09.037 |
| None |
ADMET |
CL |
25.4 |
mL.min-1.g-1 |
10.1016/j.bmc.2018.05.003 |
| None |
ADMET |
CL |
31.0 |
mL.min-1.g-1 |
10.1016/j.bmcl.2019.126769 |
| None |
ADMET |
CL |
44.5 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
CL |
59.7 |
mL.min-1.g-1 |
10.1016/j.bmcl.2020.127681 |
| None |
ADMET |
CL |
70.6 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
CL |
83.3 |
mL.min-1.g-1 |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
CL |
123.33 |
mL.min-1.kg-1 |
10.1021/acs.jmedchem.0c00628 |
| None |
ADMET |
CL |
31030.0 |
mL.min-1.g-1 |
10.1016/j.bmcl.2019.126703 |
| None |
ADMET |
CLH |
20.2 |
uL/min |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
CLH |
21.9 |
uL/min |
10.1016/j.ejmech.2016.04.052 |
| None |
ADMET |
CLH |
47.8 |
uL/min |
10.1016/j.ejmech.2021.113174 |
| None |
ADMET |
CLH |
111.8 |
uL/min |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
CLH |
140.8 |
uL/min |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
CLH |
150.1 |
uL/min |
10.1016/j.ejmech.2021.113174 |
| None |
ADMET |
Cmax |
20.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
fCmax |
0.007 |
uM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
fCmax |
4.57 |
uM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
IC50 |
500000.0 |
nM |
10.1124/dmd.112.050054 |
| None |
ADMET |
Inhibition |
25.0 |
% |
10.1124/dmd.112.050054 |
| None |
ADMET |
LD50 |
234.0 |
mg.kg-1 |
10.1016/s0960-894x(99)00415-1 |
| None |
ADMET |
T1/2 |
0.07667 |
hr |
10.1016/j.ejmech.2021.113174 |
| None |
ADMET |
T1/2 |
0.1667 |
hr |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
T1/2 |
0.2167 |
hr |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
T1/2 |
0.2417 |
hr |
10.1016/j.ejmech.2021.113174 |
| None |
ADMET |
T1/2 |
0.2767 |
hr |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
T1/2 |
0.3867 |
hr |
10.1016/j.bmcl.2020.127681 |
| None |
ADMET |
T1/2 |
0.4167 |
hr |
10.1016/j.bmcl.2021.128025 |
| None |
ADMET |
T1/2 |
0.52 |
hr |
10.1021/acs.jmedchem.1c01007 |
| None |
ADMET |
T1/2 |
0.7445 |
hr |
10.1016/j.bmcl.2019.126703 |
| None |
ADMET |
T1/2 |
0.745 |
hr |
10.1016/j.bmcl.2019.126769 |
| None |
ADMET |
T1/2 |
0.9083 |
hr |
10.1016/j.bmc.2018.05.003 |
| None |
ADMET |
T1/2 |
1.0 |
hr |
10.1021/acs.jmedchem.7b01465 |
| None |
ADMET |
T1/2 |
1.053 |
hr |
10.1016/j.ejmech.2016.04.052 |
| None |
ADMET |
T1/2 |
1.542 |
hr |
10.1016/j.bmc.2015.08.014 |
| None |
ADMET |
T1/2 |
1.542 |
hr |
10.1016/j.bmc.2017.09.037 |
| None |
ADMET |
T1/2 |
2.567 |
hr |
10.1016/j.bmc.2015.08.014 |
| None |
ADMET |
T1/2 |
2.567 |
hr |
10.1016/j.bmc.2017.09.037 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
NON-PROTEIN TARGET |
Fu |
0.82 |
None |
10.1021/jm401963n |
| None |
No relevant target |
LogD |
nan |
None |
10.1021/acs.jmedchem.7b01465 |
| None |
No relevant target |
Log Kmemb |
0.4 |
None |
10.1021/jm0309001 |
| None |
No relevant target |
Peff |
63.7 |
ucm/s |
10.1021/acs.jmedchem.9b01301 |
| None |
No relevant target |
pKa |
8.3 |
None |
10.1021/jm070524a |
| None |
No relevant target |
pKa |
10.07 |
None |
10.1124/dmd.112.050278 |
| None |
Unchecked |
Activity |
82.7 |
% |
10.1021/jm070524a |
| None |
Unchecked |
IC50 |
2415.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
1636.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
PI |
nan |
None |
10.1016/s0960-894x(99)00415-1 |
| None |
Unchecked |
Potency |
1635.3 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0004 |
None |
10.1021/acs.jmedchem.9b01301 |
| None |
Unchecked |
Ratio |
0.302 |
None |
10.1021/acs.jmedchem.9b01301 |